4//SEC Filing
Knight Robert Douglas 4
Accession 0001209191-21-010669
CIK 0001538210other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 2:51 PM ET
Size
5.6 KB
Accession
0001209191-21-010669
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Knight Robert Douglas
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-11+210,609→ 210,609 totalExercise: $17.00Exp: 2025-02-11→ Common Stock (210,609 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on the first anniversary of the grant date (the "Initial Vesting Date") (2/11/2021) and 1/48 of the shares subject to the option shall vest on each month anniversary of the Initial Vesting Date such that after four (4) years, all shares subject to the option shall be vested, subject to the participant's continuous service on each such vesting date.
Documents
Issuer
NexImmune, Inc.
CIK 0001538210
Entity typeother
Related Parties
1- filerCIK 0001844747
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 2:51 PM ET
- Size
- 5.6 KB